Integrating random walk and binary regression to identify novel miRNA-disease association

BackgroundIn the last few decades, cumulative experimental researches have witnessed and verified the important roles of microRNAs (miRNAs) in the development of human complex diseases. Benefitting from the rapid growth both in the availability of miRNA-related data and the development of various analysis methodologies, up until recently, some computational models have been developed to predict human disease related miRNAs, efficiently and quickly.ResultsIn this work, we proposed a computational model of Random Walk and Binary Regression-based MiRNA-Disease Association prediction (RWBRMDA). RWBRMDA extracted features for each miRNA from random walk with restart on the integrated miRNA similarity network for binary logistic regression to predict potential miRNA-disease associations. RWBRMDA obtained AUC of 0.8076 in the leave-one-out cross validation. Additionally, we carried out three different patterns of case studies on four human complex diseases. Specifically, Esophageal cancer and Prostate cancer were conducted as one kind of case study based on known miRNA-disease associations in HMDD v2.0 database. Out of the top 50 predicted miRNAs, 94 and 90% were respectively confirmed by recent experimental reports. To simulate new disease without known related miRNAs, the information of known Breast cancer related miRNAs was removed. As a result, 98% of the top 50 predicted miRNAs for Breast cancer were confirmed. Lymphoma, the verified ratio of which was 88%, was used to assess the prediction robustness of RWBRMDA based on the association records in HMDD v1.0 database.ConclusionsWe anticipated that RWBRMDA could benefit the future experimental investigations about the relation between human disease and miRNAs by generating promising and testable top-ranked miRNAs, and significantly reducing the effort and cost of identification works.

[1]  C. Pasquier,et al.  Prediction of miRNA-disease associations with a vector space model , 2016, Scientific Reports.

[2]  Xing Chen,et al.  RKNNMDA: Ranking-based KNN for MiRNA-Disease Association prediction , 2017, RNA biology.

[3]  M. Latronico,et al.  Emerging role of microRNAs in cardiovascular biology. , 2007, Circulation research.

[4]  Na-Na Guan,et al.  Predicting miRNA‐disease association based on inductive matrix completion , 2018, Bioinform..

[5]  G. Reifenberger,et al.  miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells , 2013, Oncogene.

[6]  Xing Chen,et al.  EGBMMDA: Extreme Gradient Boosting Machine for MiRNA-Disease Association prediction , 2018, Cell Death & Disease.

[7]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[8]  P. Neven,et al.  Aromatase inhibitors in the breast cancer clinic: focus on exemestane. , 2014, Endocrine-Related Cancer.

[9]  R. Dahiya,et al.  microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer , 2013, British Journal of Cancer.

[10]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[11]  Bernhard Puppe,et al.  MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. , 2011, Blood.

[12]  Xing Chen,et al.  NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning , 2016, PLoS Comput. Biol..

[13]  Peter Möller,et al.  Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. , 2009, Neoplasia.

[14]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[15]  Xing Chen,et al.  MicroRNAs and complex diseases: from experimental results to computational models , 2019, Briefings Bioinform..

[16]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[17]  Establishment of two-dimensional gel electrophoresis profiles of the human acute promyelocytic leukemia cell line NB4. , 2012, Molecular medicine reports.

[18]  A. Pasquinelli,et al.  Control of developmental timing by micrornas and their targets. , 2002, Annual review of cell and developmental biology.

[19]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.

[20]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[21]  W. Cho.  MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. , 2010, The international journal of biochemistry & cell biology.

[22]  Shiguang Zhao,et al.  MiR-106a is an independent prognostic marker in patients with glioblastoma. , 2013, Neuro-oncology.

[23]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[24]  A. Stewart,et al.  Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. , 2000, Journal of the American College of Surgeons.

[25]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[26]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[27]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[28]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[29]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[30]  Dongfeng Li,et al.  Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal Cancer , 2013, PloS one.

[31]  Qun Zhou,et al.  Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer , 2014, Oncogene.

[32]  Xing Chen,et al.  HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction , 2016, Oncotarget.

[33]  Tomohiko Ichikawa,et al.  Functional significance of aberrantly expressed microRNAs in prostate cancer , 2015, International journal of urology : official journal of the Japanese Urological Association.

[34]  Evelyn Wenkel,et al.  Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection , 2012, PloS one.

[35]  Yan Zhao,et al.  ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction , 2018, RNA biology.

[36]  Xantha Karp,et al.  Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.

[37]  Yi Wang,et al.  Circulating miR-155 Expression in Plasma: A Potential Biomarker for Early Diagnosis of Esophageal Cancer in Humans , 2012, Journal of toxicology and environmental health. Part A.

[38]  Xiaojun Chen,et al.  Large-scale prediction of microRNA-disease associations by combinatorial prioritization algorithm , 2017, Scientific Reports.

[39]  Mohammed Al-Shalalfa,et al.  Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures , 2013, BMC Bioinformatics.

[40]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[41]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[42]  Qionghai Dai,et al.  WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.

[43]  Yongdong Zhang,et al.  Drug-target interaction prediction: databases, web servers and computational models , 2016, Briefings Bioinform..

[44]  Chen Chen,et al.  MicroRNAs in esophageal cancer (review). , 2012, Molecular medicine reports.

[45]  Xing Chen,et al.  MCMDA: Matrix completion for MiRNA-disease association prediction , 2017, Oncotarget.

[46]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[47]  James W Jacobson,et al.  MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis. , 2007, Cancer research.

[48]  Lei Wang,et al.  BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..

[49]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[50]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[51]  Xing Chen,et al.  PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction , 2017, PLoS Comput. Biol..

[52]  P. Enzinger,et al.  Esophageal cancer. , 2003, The New England journal of medicine.

[53]  P. Bork,et al.  G2D: a tool for mining genes associated with disease , 2005, BMC Genetics.

[54]  S. Suter,et al.  Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B‐ and T‐Cell lymphomas , 2011, Genes, chromosomes & cancer.

[55]  Xing Chen,et al.  LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction , 2017, PLoS Comput. Biol..

[56]  Axel Benner,et al.  Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer , 2012, Clinical Cancer Research.

[57]  P. Bork,et al.  Association of genes to genetically inherited diseases using data mining , 2002, Nature Genetics.

[58]  Fang-Xiang Wu,et al.  A fast and high performance multiple data integration algorithm for identifying human disease genes , 2015, BMC Medical Genomics.

[59]  Changning Liu,et al.  dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.

[60]  B. Reinhart,et al.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.

[61]  T. Tuschl,et al.  Mechanisms of gene silencing by double-stranded RNA , 2004, Nature.

[62]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[63]  Jan Gorodkin,et al.  Protein-driven inference of miRNA–disease associations , 2013, Bioinform..

[64]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[65]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[66]  Shamit Soneji,et al.  Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma , 2007, International journal of cancer.

[67]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[68]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[69]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[70]  Xing Chen,et al.  MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction , 2018, PLoS Comput. Biol..

[71]  Ujjwal Maulik,et al.  Development of the human cancer microRNA network , 2010 .

[72]  G. V. Vande Woude,et al.  Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. , 2001, The American journal of pathology.

[73]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[74]  Peizhang Xu,et al.  MicroRNAs and the regulation of cell death. , 2004, Trends in genetics : TIG.

[75]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[76]  Xing Chen,et al.  Long non-coding RNAs and complex diseases: from experimental results to computational models , 2016, Briefings Bioinform..

[77]  Qionghai Dai,et al.  RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.

[78]  W Wu,et al.  Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[79]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.